DK1112739T3 - Langtidsafgivende depot-præparat - Google Patents

Langtidsafgivende depot-præparat

Info

Publication number
DK1112739T3
DK1112739T3 DK99940667.1T DK99940667T DK1112739T3 DK 1112739 T3 DK1112739 T3 DK 1112739T3 DK 99940667 T DK99940667 T DK 99940667T DK 1112739 T3 DK1112739 T3 DK 1112739T3
Authority
DK
Denmark
Prior art keywords
long
depot preparation
term depot
fat
preparation
Prior art date
Application number
DK99940667.1T
Other languages
English (en)
Inventor
Syunsuke Tani
Akihiko Sano
Hiroo Maeda
Masako Kajihara
Toshihiko Sugie
Original Assignee
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Sumitomo Pharma Co filed Critical Dainippon Sumitomo Pharma Co
Application granted granted Critical
Publication of DK1112739T3 publication Critical patent/DK1112739T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Materials For Medical Uses (AREA)
DK99940667.1T 1998-09-10 1999-09-06 Langtidsafgivende depot-præparat DK1112739T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25617098 1998-09-10
PCT/JP1999/004809 WO2000015199A1 (fr) 1998-09-10 1999-09-06 Preparation de liberation prolongee de medicament a effet durable

Publications (1)

Publication Number Publication Date
DK1112739T3 true DK1112739T3 (da) 2011-04-26

Family

ID=17288890

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99940667.1T DK1112739T3 (da) 1998-09-10 1999-09-06 Langtidsafgivende depot-præparat

Country Status (18)

Country Link
US (1) US6756048B1 (da)
EP (1) EP1112739B1 (da)
JP (1) JP4753471B2 (da)
KR (1) KR100602823B1 (da)
CN (1) CN1198599C (da)
AT (1) ATE502626T1 (da)
AU (1) AU754996B2 (da)
BR (1) BR9913596B1 (da)
CA (1) CA2342587C (da)
DE (1) DE69943299D1 (da)
DK (1) DK1112739T3 (da)
ES (1) ES2360180T3 (da)
MX (1) MXPA01002609A (da)
NZ (1) NZ510400A (da)
PT (1) PT1112739E (da)
TW (1) TWI246928B (da)
WO (1) WO2000015199A1 (da)
ZA (1) ZA200101853B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
US7363091B1 (en) * 2001-07-11 2008-04-22 Pacesetter Inc. Method of molding silicone elastomer drug carrier in an endocardial lead
NZ528240A (en) * 2003-09-23 2006-03-31 Graham Francois Duirs And Lind Treatment and control device
GB2410748A (en) * 2004-02-03 2005-08-10 Johnson & Johnson Medical Ltd Medicated polyurethane foams
JP5178506B2 (ja) * 2005-03-14 2013-04-10 バイオベンション ホールディングス リミテッド ドラッグデリバリー組成物と関連する方法
US8303536B2 (en) * 2007-08-30 2012-11-06 Sunstorm Research Corp. Implantable delivery device
WO2012018068A1 (ja) 2010-08-06 2012-02-09 大日本住友製薬株式会社 水溶性薬物放出制御製剤
CA2807224A1 (en) 2010-08-06 2012-02-09 Dainippon Sumitomo Pharma Co., Ltd. Preparation for treatment of spinal cord injury
CN102908316B (zh) * 2012-11-12 2014-07-30 西南大学 伊维菌素水溶性固体分散体及其制备方法
KR20180014778A (ko) 2015-06-03 2018-02-09 트리아스텍 인코포레이티드 제형 및 이의 용도
CN104983695B (zh) * 2015-07-17 2018-01-09 江西博莱大药厂有限公司 一种盐酸头孢噻呋脂质体冻干剂及其制备方法
JP6878417B2 (ja) * 2016-02-17 2021-05-26 トリアステック インコーポレイテッド 剤形およびそれらの使用
KR102637575B1 (ko) * 2016-10-05 2024-02-20 타이탄 파머슈티컬즈 인코퍼레이티드 버스트 방출이 감소된 약물 전달용 이식 가능한 장치
WO2019137200A1 (en) 2018-01-09 2019-07-18 Triastek, Inc. Oral drug dosage forms comprising a fixed-dose of an adhd non-stimulant and an adhd stimulant
CN112353765B (zh) * 2020-11-09 2022-05-31 山东华辰制药有限公司 一种头孢噻呋微球的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3279996A (en) 1962-08-28 1966-10-18 Jr David M Long Polysiloxane carrier for controlled release of drugs and other agents
DE2445971A1 (de) * 1974-09-24 1976-04-08 Schering Ag Arzneimittelwirkstofftraeger ii
US4191741A (en) 1978-09-22 1980-03-04 Eli Lilly And Company Removable drug implant
DE2902414A1 (de) * 1979-01-23 1980-08-07 Hoechst Ag Depotkoerper auf basis silicon- kautschuk sowie verfahren zu seiner herstellung
JPS5793909A (en) * 1980-12-03 1982-06-11 Sankyo Co Ltd Carcinostatic pharmaceutical having directivity to specific internal organ and its preparation
JPS5944310A (ja) * 1982-09-06 1984-03-12 Nippon Kayaku Co Ltd シリコ−ンゴム系徐放性製剤
JPH0761959B2 (ja) * 1985-10-11 1995-07-05 住友製薬株式会社 シリコンエラストマ−系徐放性製剤
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
JPH0778017B2 (ja) * 1985-12-28 1995-08-23 住友製薬株式会社 パルス的かつ持続放出性製剤
JPH04224513A (ja) * 1990-12-26 1992-08-13 Olympus Optical Co Ltd 徐放剤用担体およびその製造方法
US5153002A (en) * 1991-03-04 1992-10-06 University Of Montreal Biocompatible gradient controlled release implant
JPH0778017A (ja) * 1993-06-30 1995-03-20 Kobe Steel Ltd 動作物体間の干渉チェック方法及びその装置
US5490962A (en) * 1993-10-18 1996-02-13 Massachusetts Institute Of Technology Preparation of medical devices by solid free-form fabrication methods
JP3720386B2 (ja) * 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
JPH07330581A (ja) * 1994-06-08 1995-12-19 Mitsui Toatsu Chem Inc 埋込型徐放性免疫抑制剤

Also Published As

Publication number Publication date
CN1316900A (zh) 2001-10-10
DE69943299D1 (de) 2011-05-05
AU754996B2 (en) 2002-11-28
BR9913596B1 (pt) 2014-12-23
MXPA01002609A (es) 2002-04-08
ES2360180T3 (es) 2011-06-01
KR100602823B1 (ko) 2006-07-19
JP4753471B2 (ja) 2011-08-24
CA2342587A1 (en) 2000-03-23
EP1112739B1 (en) 2011-03-23
CN1198599C (zh) 2005-04-27
KR20010072691A (ko) 2001-07-31
EP1112739A1 (en) 2001-07-04
ATE502626T1 (de) 2011-04-15
PT1112739E (pt) 2011-03-31
CA2342587C (en) 2008-11-18
EP1112739A4 (en) 2009-05-27
BR9913596A (pt) 2001-05-22
AU5449399A (en) 2000-04-03
TWI246928B (en) 2006-01-11
ZA200101853B (en) 2001-11-14
US6756048B1 (en) 2004-06-29
NZ510400A (en) 2003-03-28
WO2000015199A1 (fr) 2000-03-23

Similar Documents

Publication Publication Date Title
DK1112739T3 (da) Langtidsafgivende depot-præparat
NZ217957A (en) 3-oxadiazole-imidazo quinoxalines, their preparation, and pharmaceutical compositions
WO1998029105A3 (en) Method of treating prostatic diseases using delayed and/or sustained release vitamin d formulations
DE3583799D1 (de) Feste zubereitung mit langsamer freisetzung.
BR0311313A (pt) Derivados de diaril uréia úteis para o tratamento de doenças dependentes de proteìna cinase
DE69942928D1 (de) Therapeutische formulierung zur verabreichung von tolterodin mit kontrollierter freisetzung
BR0102040A (pt) Uso de paclitaxel estabilizado com albumina para preparação de uma droga para o tratamento de tumores sólidos e a droga desse modo obtida
DE60001451D1 (de) 1,4-diazabicyclo[3.2.2]nonan-4-carboxylat und carboxamidderivate, ihre herstellung und therapeutische verwendung
WO2001087227A3 (en) Drug containing polymeric micelles
ES2171933T3 (es) Derivados de androsteno.
ATE220547T1 (de) Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
AR018612A1 (es) DERIVADOS DE 2-(2-METILFENIL)-3,4-DIHIDRO-2H-PIRROL, PROCEDIMIENTO PARA SU OBTENCIoN, COMPUESTOS INTERMEDIARIOS uTILES PARA PREPARAR DICHOS COMPUESTOS, COMPOSICIONES PESTICIDAS, EMPLEO DE DICHOS COMPUESTOS PARA LA LUCHA CONTRA LAS PESTES, EXCLUIDO EL TRATAMIENTO TERAPÉUTICO EN ANIMALES Y SERES HUMAN
PT1181047E (pt) Composicao compreendendo esfingomielinase alcalina para utilizacao como preparacao distetica suplemento alimentar ou produto farmaceutico
EE03663B1 (et) Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine
PT1041985E (pt) Combinacao de compostos benzociclo-heptapiridina e farmacos antineoplasicos para tratar doencas proliferativas
ATE281155T1 (de) Medikamentöse verabreichung von proteinen aus polymergemischen
PT900563E (pt) Producao de formulacoes farmaceuticas para o tratamento de edema e doencas venosas
AU3401093A (en) Therapeutic agent for threatened abortion
ITRM990339A0 (it) Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali deriva
HUP0104238A2 (en) Benzoxazole derivatives and drugs containing the same as the active ingredient and their use
ATE132877T1 (de) Emulgatorfreie emulsionspolymere in pharmazeutischen zubereitungen mit verzögerter wirkstofffreigabe und ihre herstellung
FR2572932B1 (fr) Medicament insoluble administre localement dans l'oreille
DE69926633D1 (de) Injizierbare arzneiformulierungen von partricin derivaten
AUPQ223999A0 (en) Intracellular feedback controls in the diagnosis and treatment of human disease
ECSP972004A (es) Absorcion programada de una substancia farmaceutica 2,6- dimetil 4-(2 nitrofenil) -1,4- dihidropiridin- 3,5- dicarboxilato de dimetilo ( nifedipina)